Millennium Biltmore Hotel
Los Angeles

Downtown Los Angeles, California


SYMPOSIUM INFORMATION

>General Information
>Faculty
>Program/Schedule
>Accreditation
>Registration
>Hotel Reservations
>Download Brochure

 

Supported by:
GOOD SAMARITAN HOSPITAL
Los Angeles, CA

Officially Endorsed by:
THE HEART FAILURE SOCIETY OF AMERICA

Affiliated With:
INTERNATIONAL ACADEMY OF CARDIOLOGY

Related Conferences:


21st Annual

Heart Failure 2017
Update on Diagnosis and Therapy

FACULTY

PROGRAM DIRECTOR

Uri Elkayam, MD, FACC
Professor of Medicine
Keck School of Medicine
University of Southern California
Los Angeles, CA

PROGRAM CO-DIRECTOR

Anil K. Bhandari, MD, FACC, FHRS
Director, Electrophysiology
Director, EPS Fellowship Program
Chair, CME Program
Good Samaritan Hospital
Associate Clinical Professor of Medicine
University of Southern California
Los Angeles, CA

INVITED SPEAKERS

Francisco A. Arabía, MD
Co-Director, Division of Cardiothoracic Surgery
Surgical Director, Mechanical Circulatory Support Program
Cedars-Sinai Medical Center
Los Angeles, CA

Barry Borlaug, MD
Associate Professor of Medicine
Cardiovascular Diseases
Mayo Clinic
Rochester, MN

Steven Burstein, MD, FACC
Director of Interventional Cardiology and
Structural Heart Disease
Good Samaritan Hospital
Los Angeles, CA

David S. Cannom, MD, FACC, FHRS
Medical Director of Cardiology, Good Samaritan Hospital
Director of Cardiovascular Trial Development and Engagement,
Cedars-Sinai Heart Institute
Clinical Professor of Medicine
UCLA School of Medicine
Los Angeles, CA

Maria Rosa Costanzo, MD, FACC, FAHA
Medical Director, Midwest Heart Specialists Heart Failure and
Pulmonary Hypertension Programs
Medical Director, Edward Hospital Center for Advanced Heart Failure
Edward Heart Hospital
Naperville, IL

Luanda Grazette, MD, FACC
Co-Director, Advanced Heart Failure and Cardiomyopathy
Associate Professor of Clinical Medicine
Keck School of Medicine
University of Southern California
Los Angeles, CA

Barry H. Greenberg, MD, FACC
Distinguished Professor of Medicine
Director, Advanced Heart Failure Treatment Program
University of California San Diego Medical Center
La Jolla, CA

Yehuda Handelsman, MD, FACP, FACE, FNLA
Medical Director & Principal Investigator, Metabolic Institute of America
Past President of American College of Endocrinology and the American
Association of Clinical Endocrinologists
President Elect of the Pacific Lipid Assocation
Tarzana, CA

Ray V. Matthews, MD, FACC
Chief, Cardiovascular Medicine
Professor of Clinical Medicine
University of Southern California
Los Angeles, CA

Tien M.H. Ng, PharmD, FCCP, BCPS (AQ-C)
Associate Professor of Clinical Pharmacy and Medicine
Director, PGY2 Residency in Cardiology
School of Pharmacy & Keck School of Medicine
University of Southern California
Los Angeles, CA

Craig Selzman, MD
Professor of Surgery
Chief, Division of Cardiothoracic Surgery
Surgical Director, Cardiac Mechanical Support and Heart Transplant
University of Utah Health Sciences Center
Salt Lake City, UT

Pam R. Taub, MD, FACC
Director of Step Family Foundation Cardiovascular Rehabilitation and
Wellness Center
Associate Professor of Medicine
UC San Diego Health System
Division of Cardiovascular Medicine
La Jolla, CA

John R. Teerlink, M.D., FACC, FAHA, FESC, FHFSA, FRCP
Professor of Medicine, University of California, San Francisco
Director, Heart Failure
Director, Clinical Echocardiography
San Francisco Veterans Affairs Medical Center
San Francisco, CA

FACULTY DISCLOSURE
It is our policy to ensure balance, independence, objectivity and scientific rigor. All persons involved in the selection, development and presentation of content are required to disclose any real or apparent conflicts of interest. All conflicts of interest will be resolved prior to an educational activity being delivered to learners through one of the following mechanisms 1) altering the financial relationship with the commercial interest, 2) altering the individual’s control over CME content about the products or services of the commercial interest, and/or 3) validating the activity content through independent peer review. All persons are also required to disclose any discussions of off label/unapproved uses of drugs or devices. Persons who refuse or fail to disclose are disqualified from participating in the CME activity. Participants will be asked to evaluate whether the speaker’s outside interests reflect a possible bias in the planning or presentation of the activity. This information is used to plan future activities.